GENEVA, Aug. 14 -- GENERATE BIOMEDICINES, INC. filed a patent application (US2026/014355) for “ANTI-IL-13 ANTIBODIES AND METHODS OF USE THEREOF”. With publication no. WO/2026/170046, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/24
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....